2.1 The Recovery Paradigm: Symptom Control to Functional Outcomes
For many years, SSD treatment focused mostly on using medication to control symptoms. Doctors tried to prevent relapses and manage the most disruptive problems, and this method is well supported by evidence, especially early in the illness. Studies show that antipsychotics help many people avoid relapse, so clinical guidelines recommend them (Correll, Rubio, & Kane, 2018). Still, newer research suggests that treatment goals should be broader.
However, medication is only one part of treatment. Many experts now believe that just reducing symptoms is not enough. People with SSD want to succeed in school, work, stay healthy, and have relationships. Studies, including the OPUS program for first-episode psychosis, show that negative symptoms like low motivation and social withdrawal, as well as thinking problems, often affect life outcomes more than positive symptoms like hallucinations or delusions. Recent meta-analyses show that only about one-third of people with first-episode psychosis reach functional recovery, so many continue to have symptoms that affect thinking and daily life (A.C. et al., 2021).
After diagnosis, people’s lives can go in many directions. Some keep their roles and relationships, while others face major challenges. Structural brain abnormalities associated with psychosis spectrum symptoms have been observed in youth, indicating that changes can arise as early as adolescence (T.D. et al., 2016). Consequently, treatment approaches should not only address symptom reduction but also emphasize support for social functioning and daily role recovery (Galletly et al., 2016; Starzer et al., 2023).
Positive Psychology (PP) offers a new approach. It focuses on strengths people already have, such as resilience, hope, and a sense of meaning in life. These qualities can help protect against illness and support recovery. Research shows that building self-esteem and accepting the illness often leads to better relationships and well-being (Gerymski & Szeląg, 2023). Some therapies now help people with long-term mental health issues feel more confident and optimistic by building these skills. While earlier studies were small or in early stages, larger studies show a clinical recovery rate of 20.8% for people with first-episode schizophrenia after about 9.5 years (Clinical Recovery Among Individuals With a First-Episode Schizophrenia: An Updated Systematic Review and Meta-Analysis, 2022). However, feeling better in assessments does not always mean real improvements in daily life. Some long-term studies found that symptom relief does not always match improvements in happiness or social recovery, so it is important to focus on personal well-being as well as symptoms (Association of Antipsychotic Treatment and Side Effects With Societal Recovery and Happiness: A Naturalistic Cohort Study of People in Long-term Care for a Psychotic Disorder, 2023). Research suggests that building psychological strengths can lower anxiety, help people take part in daily life, and improve well-being. New guidelines recommend combining medical and psychological care, especially early on (Correll et al., 2018; Galletly et al., 2016).
2.2 Positive Psychology and the Integration of Recovery Constructs
Positive Psychology (PP) provides an important experiential and theoretical complement to traditional approaches by emphasizing endogenous psychological resources, such as resilience, hope, meaning in life, and subjective well-being (SWB). These resources function both as buffers against illness-related risk and as drivers of recovery processes. Cross-population studies have shown that the negative impact of illness uncertainty on SWB is mediated by resilience and illness acceptance, while increases in self-esteem and acceptance are associated with higher levels of well-being and relationship quality (Gerymski & Szeląg, 2023).
Intervention studies further suggest that positive-oriented psychotherapies—encompassing techniques that focus on strengths, positive emotions, and meaning—can enhance self-efficacy and positive affect in individuals with chronic mental disorders. These findings indicate potential specificity for core deficits of negative symptoms, such as avolition and anhedonia. Although the current evidence base largely consists of pilot and early-stage studies, including preliminary data from psychosis-spectrum samples, the results underscore the need for larger-scale trials with extended follow-up periods (Kasperek-Zimowska et al., 2021).
Importantly, longitudinal evidence also indicates that improvements in clinical indicators do not fully overlap with gains in subjective well-being. A five-year follow-up study found only partial convergence between clinical recovery and subjective well-being, highlighting a degree of decoupling between these domains and reinforcing the need to incorporate subjective outcomes into recovery assessment frameworks (Meesters et al., 2023).
PP constructs and recovery goals may be theoretically integrated within a testable mechanistic framework, in which psychological resources are posited to alleviate negative affect and illness-related uncertainty, thereby promoting sustained engagement in everyday activities and social participation and, consequently, improving subjective well-being and functional outcomes. Such a framework is congruent with current clinical guidelines that advocate for integrated treatment approaches combining pharmacological and psychosocial interventions, particularly in the context of first-episode and early-stage schizophrenia spectrum disorders (SSD) (Correll et al., 2018; Galletly et al., 2016).
2.3 Biomedical Themes and the Necessity of Quantitative Integration
With the broader acceptance of recovery-oriented perspectives, biomedical research has expanded its outcome frameworks to encompass more than acute symptoms and short-term relapse. Current research now includes long-term endpoints such as physical comorbidities, metabolic risk, all-cause mortality, and quality of life. A 20-year nationwide cohort study from Finland demonstrated that continuous antipsychotic treatment, compared with non-use, was associated with significantly lower risks of all-cause, cardiovascular, and suicide mortality. For instance, the adjusted hazard ratio for all-cause mortality was approximately 0.48. These findings indicate that excess mortality may be attributable to treatment discontinuation or non-use, rather than antipsychotic exposure itself (Taipale et al., 2020).
Ongoing debates persist regarding the long-term effectiveness and risk–benefit balance of antipsychotic treatment. Although systematic reviews consistently support robust short- and medium-term relapse prevention, high-quality randomized controlled trials assessing long-term outcomes remain limited. Additionally, the metabolic and motor side effects associated with antipsychotic use require concurrent psychosocial and lifestyle interventions to mitigate their impact (Correll et al., 2018). Evidence from a national cohort of over 62,000 individuals further suggests that, during the maintenance phase, certain forms of rational polypharmacy, such as clozapine combined with aripiprazole, may reduce rehospitalization risk more effectively than optimal monotherapy (clozapine alone). This finding refines and contextualizes the traditional assumption that monotherapy should always be preferred (Tiihonen et al., 2019).
At the mechanistic level, guidelines from the European Psychiatric Association (EPA) identify cognitive impairment as a core determinant of functional disability, often exerting a greater disruptive effect on real-world functioning than positive or negative symptoms. Consequently, cognitive functioning is recognized as a strong predictor of employment among individuals with severe mental illness, underscoring the importance of assessing and remediating cognitive deficits to improve work outcomes and social participation (Impact of cognitive remediation on the prediction of employment outcomes in severe mental illness, 2022). This perspective has led neuroimaging and pathophysiological research to move beyond viewing structural or functional brain alterations as endpoints, instead positioning social cognition and quality of life as downstream, quantifiable outcomes within a biopsychological pathway. This approach establishes a validation framework for cross-level integration.
2.4 External Environmental Shocks and the Application of Topic Modeling
The evolution of the academic ecosystem is characterized by non-linear dynamics. The COVID-19 pandemic (2020–2022) prompted abrupt reallocations of healthcare and research resources, resulting in a temporary concentration of psychiatric research on post-infection neuropsychiatric sequelae and population-level risk. During this period, there was a rapid accumulation of prospective follow-up studies of hospitalized patients and large-scale analyses of mental health outcomes in population-based databases, reflecting an acute-event-driven shift in research focus (Huang et al., 2021/2023; Wang et al., 2024). For instance, a nationwide study in Denmark identified over 5.8 million individuals and found that nearly 95,000 people had at least one hospital contact with a psychiatric diagnosis in 2020 (Mental health disorders before, during and after the COVID-19 pandemic: a nationwide study, 2024).
In research related to SSD–PP, the exogenous shock of the COVID-19 pandemic resulted in a marked change in publication patterns, characterized by a sharp increase in COVID-19-related publications and a relative decline in non-COVID-19 research output. Traditional bibliometric indicators, such as publication volume or citation counts, do not fully capture this shift, as they may overlook subtle temporal topic changes and evolving cross-topic connections (Aviv-Reuven & Rosenfeld, 2020).
BERTopic, which utilizes semantic embeddings, represents topics as high-dimensional vectors and enables the tracking of proportional changes over time. It also facilitates the calculation of semantic proximity between topics, thereby transforming integration into a reproducible quantitative indicator. In this study, topic modeling was employed to identify major thematic clusters and to conduct a comprehensive semantic analysis across multiple years (Lin et al., 2025). Furthermore, the semantic similarity between a core positive psychology topic (T10: subjective well-being) and a core pathology/neuroimaging topic (T14: brain imaging and neural mechanisms) was quantified as a cosine similarity of 0.6780. This value serves as an operationalized measure of bio-psychological integration, supporting the empirical analysis of paradigm shifts from binary separation to multidimensional convergence (Cerebral cortical structural alteration patterns across four major psychiatric disorders in 5549 individuals, 2023). Methodologically, the primary advantage of this approach is its ability to simultaneously capture temporal dynamics and cross-topic coupling within a unified semantic space.